Question: I’ve heard that the FDA wants medical device companies to take a more comprehensive view of product life cycles. However, we are not sure what is expected from the regulations and how they might integrate into our product development process. We are currently using a phased and gated product development process. Can you provide some insight?
Answer: The FDA Center for Device and Radiological Health (CDRH) has included product life cycle as a strategic priority for several years. As part of addressing this strategic priority, they are currently focused on how to use pre- and post-market data. In April, 2015, CDRH released the guidance document “Balancing Premarket and Postmarket Data Collection for Devices Subject to Premarket Approval.” While this is specific to Premarket Approval (PMA) products, the thought process makes sense for most products. The approach uses a Risk-Benefit analysis to provide patient access to safe, high quality devices while capturing relevant data which is often difficult to collect prior to market introduction, such as rare events or long term reliability in actual use.
Your phased and gated process is a business process, while design controls and other regulatory requirements are a subset of activities within the process. Your phased and gated process includes a post-launch period where you collect market feedback. To integrate the life cycle requirements, you need to consider what additional information, related to product safety and efficacy, you need to collect.
The following steps will enable you to integrate product premarket and post-market data collection into your process.
Integrating the guidance on premarket and post-market data collection into a phased and gated product development process can be done. You need to remember that the phased and gated process is a business process. Premarket and post-market data collection becomes part of the project’s design control activities which are captured in the DDP.
Strategy 2 Market helps companies increase growth and decrease product development complexity. www.strategy2market.com
For more information or to speak with one of our consultants, please contact Mary Drotar at 312-212-3144 or [email protected]